The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor, and brain-derived neurotrophic factor in aged mice

Author： Jiang Lihe   Shi Yan   Long Yin   Yang Zhirong  

Publisher： Informa Healthcare

ISSN： 1388-0209

Source： Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol.47, Iss.7, 2009-07, pp. : 584-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nerve growth factor and brain-derived neurotrophic factor: potential targets for migraine treatment?

By Sarchielli Paola   Nardi Katiuscia   Mancini Maria Luisa   Corbelli Ilenia   Tambasco Nicola   Chiasserini Davide   Calabresi Paolo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 7, 2008-07 ,pp. : 705-721

Informa Healthcare

Access to resources Recommend Favorite

Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models

By  

Current Neuropharmacology, Vol. 1, Iss. 2, 2003-06 ,pp. : 109-123

Bentham Science Publishers

Access to resources Recommend Favorite

Brain-Derived Neurotrophic Factor and Antidepressant Activity

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1495-1510

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway

By Vaka Siva   Murthy Sathyanarayana   Balaji Anna   Repka Michael  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 441-447

Springer Publishing Company

Access to resources Recommend Favorite

Brain-derived neurotrophic factor as a drug target for CNS disorders

By Pezet Sophie   Malcangio Marzia  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 391-399

Informa Healthcare

Access to resources Recommend Favorite